Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tumor suppressor candidate 7 (TUSC7) is a long non-coding RNA (lncRNA) of approximately 2.1 kb encoded at chromosome 3q13.31. It acts as a tumor suppressor in various cancers by regulating cell proliferation, apoptosis, migration, and invasion. TUSC7 functions, in part, by sponging oncogenic microRNAs, including miR-23b and miR-211, reciprocally inhibiting their activity. Its expression is typically downregulated in several malignancies, and reduced TUSC7 levels are associated with increased tumor aggressiveness and poor patient prognosis. TUSC7 is also a direct transcriptional target of the tumor suppressor p53. No approved drugs directly target TUSC7, but preclinical studies suggest its modulation may be a valuable approach for tumor suppression and as a prognostic biomarker.
TUSC7 acts as a molecular sponge for oncogenic microRNAs including miR-23b, miR-211, and miR-10a, leading to decreased proliferation, migration, and increased apoptosis in cancer cells. It is also involved in p53 pathway regulation, as TUSC7 is regulated by p53 and mediates some p53-dependent tumor suppressor activity in certain contexts.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tumor suppressor candidate 7 (non-protein coding) (TUSC7).